AstraZeneca Pharma India Limited (BOM:506820)
8,765.10
+36.60 (0.42%)
At close: Aug 8, 2025
AstraZeneca Pharma India Company Description
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.
The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.
AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Limited
Country | India |
Founded | 1979 |
Industry | Pharmaceutical Preparations |
Employees | 802 |
CEO | Praveen Akkinepally |
Contact Details
Address: Manyata Embassy Business Park Bengaluru, 560045 India | |
Phone | 91 80 6774 8000 |
Website | astrazeneca.in |
Stock Details
Ticker Symbol | 506820 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Praveen Akkinepally | Chief Executive Officer |
Bhavana Agrawal | Chief Financial Officer |